SCHEMBL8976303

SCHEMBL8976303

C/C(=C\c1ccccc1)CN1CCN(Cc2ccc(Cl)cc2)CC1

nearest known ligand 0.65

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.62
USP2 O75604 1/20 0.62
ALOX15 P16050 1/20 0.62
TSHR P16473 1/20 0.62
ALDH1A1 P00352 1/20 0.62
TDP1 Q9NUW8 1/20 0.62
SIGMAR1 Q99720 1/20 0.59
DRD4 P21917 2/20 0.54
KDM4E B2RXH2 2/20 0.54
MEN1 O00255 3/20 0.53
KMT2A Q03164 3/20 0.53
MAPT P10636 2/20 0.52
MAPK1 P28482 2/20 0.52
LMNA P02545 1/20 0.52
GPR183 P32249 1/20 0.51
ATM Q13315 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8976310 1.00 SMN1; SMN2 (0.62) SMN1; SMN2USP2ALOX15TSHRALDH1A1
SCHEMBL8976340 0.91 SMN1; SMN2 (0.68) SMN1; SMN2USP2ALOX15TSHRALDH1A1
SCHEMBL8976337 0.91 SMN1; SMN2 (0.68) SMN1; SMN2USP2ALOX15TSHRALDH1A1
SCHEMBL8976338 0.89 SMN1; SMN2 (0.62) SMN1; SMN2USP2ALOX15TSHRALDH1A1
SCHEMBL8976331 0.89 SMN1; SMN2 (0.62) SMN1; SMN2USP2ALOX15TSHRALDH1A1
SCHEMBL8976614 0.85 SIGMAR1 (0.65) SMN1; SMN2USP2ALOX15TSHRALDH1A1
SCHEMBL8976616 0.85 SIGMAR1 (0.65) SMN1; SMN2USP2ALOX15TSHRALDH1A1
SCHEMBL13539640 0.79 TSHR (0.72) SMN1; SMN2USP2ALOX15TSHRALDH1A1
SCHEMBL8976630 0.79 MEN1 (0.67) SMN1; SMN2ALDH1A1SIGMAR1DRD4KDM4E
SCHEMBL8976627 0.79 MEN1 (0.67) SMN1; SMN2ALDH1A1SIGMAR1DRD4KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0707004-A1 1-Arylalcenyl 4-arylmethylpiperazinderivatives, process for their preparation and pharmaceutical composition containing them ADIR ET COMPAGNIE (FR) 1996-04-17 EP disclosed